Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 1
2003 1
2006 1
2008 4
2009 5
2010 9
2011 6
2012 6
2013 8
2014 14
2015 11
2016 11
2017 5
2018 6
2019 7
2020 2
2021 1
2022 4
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

93 results

Results by year

Filters applied: . Clear all
Page 1
Targeting CHAF1B Enhances IFN Activity against Myeloproliferative Neoplasm Cells.
Saleiro D, Kosciuczuk EM, Fischietti M, Perez RE, Yang GS, Eckerdt F, Beauchamp EM, Hou Y, Wang Q, Weinberg RS, Fish EN, Yue F, Hoffman R, Platanias LC. Saleiro D, et al. Cancer Res Commun. 2023 May 31;3(5):943-951. doi: 10.1158/2767-9764.CRC-23-0010. eCollection 2023 May. Cancer Res Commun. 2023. PMID: 37377894 Free PMC article.
Targeting ULK1 Decreases IFNγ-Mediated Resistance to Immune Checkpoint Inhibitors.
Fenton SE, Zannikou M, Ilut L, Fischietti M, Ji C, Oku CV, Horvath CM, Le Poole IC, Bosenberg M, Bartom ET, Kocherginsky M, Platanias LC, Saleiro D. Fenton SE, et al. Mol Cancer Res. 2023 Apr 1;21(4):332-344. doi: 10.1158/1541-7786.MCR-22-0684. Mol Cancer Res. 2023. PMID: 36573964 Free PMC article.
SLFN11 negatively regulates non-canonical NFkB signaling to promote glioblastoma progression.
Fischietti M, Eckerdt F, Perez RE, Guillen Magaña JN, Mazewski C, Ho S, Gonzalez C, Streich LD, Beauchamp EM, Heimberger AB, Baran AH, Yue F, James CD, Platanias LC. Fischietti M, et al. Cancer Res Commun. 2022 Sep;2(9):966-978. doi: 10.1158/2767-9764.crc-22-0192. Epub 2022 Sep 13. Cancer Res Commun. 2022. PMID: 36382088 Free PMC article.
Discovery of a signaling feedback circuit that defines interferon responses in myeloproliferative neoplasms.
Saleiro D, Wen JQ, Kosciuczuk EM, Eckerdt F, Beauchamp EM, Oku CV, Blyth GT, Fischietti M, Ilut L, Colamonici M, Palivos W, Atsaves PA, Tan D, Kocherginsky M, Weinberg RS, Fish EN, Crispino JD, Hoffman R, Platanias LC. Saleiro D, et al. Nat Commun. 2022 Apr 1;13(1):1750. doi: 10.1038/s41467-022-29381-7. Nat Commun. 2022. PMID: 35365653 Free PMC article.
Schlafen 5 as a novel therapeutic target in pancreatic ductal adenocarcinoma.
Fischietti M, Eckerdt F, Blyth GT, Arslan AD, Mati WM, Oku CV, Perez RE, Lee-Chang C, Kosciuczuk EM, Saleiro D, Beauchamp EM, Lesniak MS, Verzella D, Sun L, Fish EN, Yang GY, Qiang W, Platanias LC. Fischietti M, et al. Oncogene. 2021 May;40(18):3273-3286. doi: 10.1038/s41388-021-01761-1. Epub 2021 Apr 12. Oncogene. 2021. PMID: 33846574 Free PMC article.
Combined PI3Kα-mTOR Targeting of Glioma Stem Cells.
Eckerdt FD, Bell JB, Gonzalez C, Oh MS, Perez RE, Mazewski C, Fischietti M, Goldman S, Nakano I, Platanias LC. Eckerdt FD, et al. Sci Rep. 2020 Dec 14;10(1):21873. doi: 10.1038/s41598-020-78788-z. Sci Rep. 2020. PMID: 33318517 Free PMC article.
Inhibitory effects of SEL201 in acute myeloid leukemia.
Kosciuczuk EM, Kar AK, Blyth GT, Fischietti M, Abedin S, Mina AA, Siliezar R, Rzymski T, Brzozka K, Eklund EA, Beauchamp EM, Eckerdt F, Saleiro D, Platanias LC. Kosciuczuk EM, et al. Oncotarget. 2019 Dec 24;10(67):7112-7121. doi: 10.18632/oncotarget.27388. eCollection 2019 Dec 24. Oncotarget. 2019. PMID: 31903169 Free PMC article.
93 results